Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thoracic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484
What this trial is testing

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more
Revolution Medicines, Inc. 590
Testing effectiveness (Phase 2)Study completedNCT01853878
What this trial is testing

Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Testing effectiveness (Phase 2)Ended earlyNCT00281021
What this trial is testing

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 26
Not applicableUnknownNCT05221814
What this trial is testing

Pathological Classification of Pulmonary Nodules in Images Using Deep Learning

Who this might be right for
Lung CancerArtificial Intelligence
Jiangxi Provincial Cancer Hospital 2,000
Not applicableStudy completedNCT01687738
What this trial is testing

Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention

Who this might be right for
Non-small Cell Lung Cancer
University of North Carolina, Chapel Hill 238
Early research (Phase 1)Not Yet RecruitingNCT06743555
What this trial is testing

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 14
Not applicableStudy completedNCT00342264
What this trial is testing

A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 1,187
Testing effectiveness (Phase 2)Study completedNCT01037998
What this trial is testing

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 115
Not applicableStudy completedNCT06607393
What this trial is testing

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
Aetion, Inc. 851
Not applicableNot Yet RecruitingNCT06115447
What this trial is testing

Polypropylene vs Polyglactin in Suturing of the Lung

Who this might be right for
Lung InjuryBleb LungLung Cancer
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Not applicableStudy completedNCT05435885
What this trial is testing

Postoperative Telerehabilitation in Older Adults

Who this might be right for
TelerehabilitationCarcinoma, Non-Small-Cell LungCardiopulmonary Exercise Test
Pusan National University Hospital 64
Testing effectiveness (Phase 2)Study completedNCT01222936
What this trial is testing

LBH Phase II in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Southern Europe New Drug Organization 21
Testing effectiveness (Phase 2)Study completedNCT00318136
What this trial is testing

Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 47
Not applicableLooking for participantsNCT06983899
What this trial is testing

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

Who this might be right for
Lung Non-Small Cell Carcinoma
Fred Hutchinson Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT05527821
What this trial is testing

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Who this might be right for
Unresectable Advanced Solid TumorsBiliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableLooking for participantsNCT07465848
What this trial is testing

Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

Who this might be right for
Lung Cancer (Diagnosis)Health Adult SubjectsPatient
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe) 1,200
Next Page